Variant report
Variant | esv1819717 |
---|---|
Chromosome Location | chr3:607873-660522 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:110)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr3:638972-639242 | GM12878 | blood: | n/a | chr3:639093-639102 |
2 | BRCA1 | chr3:638578-639330 | Hela-S3 | cervix: | n/a | n/a |
3 | BRCA1 | chr3:649451-649478 | Hela-S3 | cervix: | n/a | n/a |
4 | BRCA1 | chr3:639591-639851 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr3:638934-639824 | Hela-S3 | cervix: | n/a | n/a |
6 | CEBPB | chr3:650024-650224 | A549 | lung: | n/a | chr3:650073-650084 chr3:650075-650084 |
7 | CEBPB | chr3:649955-650248 | IMR90 | lung: | n/a | chr3:650073-650084 chr3:650075-650084 |
8 | CEBPB | chr3:650039-650244 | HepG2 | liver: | n/a | chr3:650073-650084 chr3:650075-650084 |
9 | CEBPB | chr3:611097-611344 | HepG2 | liver: | n/a | chr3:611201-611212 |
10 | CEBPB | chr3:637765-638119 | Hela-S3 | cervix: | n/a | n/a |
11 | CEBPB | chr3:649124-649464 | Hela-S3 | cervix: | n/a | n/a |
12 | CHD2 | chr3:639101-639345 | Hela-S3 | cervix: | n/a | n/a |
13 | CTCF | chr3:658448-658477 | ProgFib | skin: | n/a | n/a |
14 | CTCF | chr3:658486-658533 | A549 | lung: | n/a | n/a |
15 | CTCF | chr3:616998-617162 | Hela-S3 | cervix: | n/a | n/a |
16 | CTCF | chr3:616980-617130 | HEK293 | kidney: | n/a | n/a |
17 | CTCF | chr3:623741-623815 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr3:616980-617130 | HEEpiC | esophagus: | n/a | n/a |
19 | CTCF | chr3:655980-656130 | GM12875 | blood: | n/a | n/a |
20 | CTCF | chr3:612787-612876 | GM13976 | blood: | n/a | n/a |
21 | CTCF | chr3:616940-617090 | A549 | lung: | n/a | n/a |
22 | CTCF | chr3:617015-617090 | LNCaP | prostate: | n/a | n/a |
23 | CTCF | chr3:641109-641158 | ProgFib | skin: | n/a | n/a |
24 | CTCF | chr3:616960-617110 | Hela-S3 | cervix: | n/a | n/a |
25 | CTCF | chr3:617062-617147 | MCF-7 | breast: | n/a | n/a |
26 | CTCF | chr3:618424-618441 | LNCaP | prostate: | n/a | n/a |
27 | CTCF | chr3:615631-615719 | ProgFib | skin: | n/a | n/a |
28 | CTCF | chr3:659480-659630 | GM12875 | blood: | n/a | n/a |
29 | CTCF | chr3:616960-617110 | SK-N-SH_RA | brain: | n/a | n/a |
30 | CTCF | chr3:616980-617130 | Caco-2 | colon: | n/a | n/a |
31 | CTCF | chr3:616960-617110 | GM12865 | blood: | n/a | n/a |
32 | CTCF | chr3:608164-608208 | GM20000 | blood: | n/a | n/a |
33 | CTCF | chr3:612832-612875 | ProgFib | skin: | n/a | n/a |
34 | CTCF | chr3:616960-617110 | GM12870 | blood: | n/a | n/a |
35 | CTCF | chr3:616960-617110 | WERI-Rb-1 | eye: | n/a | n/a |
36 | CTCF | chr3:623765-623780 | ProgFib | skin: | n/a | n/a |
37 | CTCF | chr3:650545-650626 | ProgFib | skin: | n/a | n/a |
38 | CTCF | chr3:626000-626150 | NHDF-neo | bronchial: | n/a | n/a |
39 | CTCF | chr3:616940-617090 | HepG2 | liver: | n/a | n/a |
40 | ELK1 | chr3:639661-639775 | Hela-S3 | cervix: | n/a | n/a |
41 | ELK1 | chr3:639134-639183 | Hela-S3 | cervix: | n/a | n/a |
42 | EP300 | chr3:638941-639877 | Hela-S3 | cervix: | n/a | chr3:639272-639286 |
43 | EP300 | chr3:620995-621568 | SK-N-SH | brain: | n/a | n/a |
44 | FOS | chr3:614457-614821 | HUVEC | blood vessel: | n/a | n/a |
45 | FOXA2 | chr3:623512-623895 | A549 | lung: | n/a | n/a |
46 | FOXP2 | chr3:609428-609783 | SK-N-MC | brain: | n/a | n/a |
47 | GABPA | chr3:638980-639383 | Hela-S3 | cervix: | n/a | n/a |
48 | GATA2 | chr3:621236-621544 | SH-SY5Y | brain: | n/a | chr3:621342-621349 chr3:621342-621353 chr3:621342-621349 chr3:621335-621356 chr3:621337-621353 chr3:621342-621349 |
49 | GATA3 | chr3:620053-620583 | SH-SY5Y | brain: | n/a | chr3:620504-620525 |
50 | GATA3 | chr3:636965-637085 | SH-SY5Y | brain: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL5RA-14 | chr3:659472-659997 | NONHSAT087571 |
2 | lnc-CHL1-6 | chr3:608788-608866 | ucscGeneNc_uc003boy_1 |
3 | lnc-CHL1-3 | chr3:633788-633866 | NR_110118 |
4 | lnc-CHL1-3 | chr3:633788-633866 | ENSG00000224957 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238075 | TF binding region |
DCBLD2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543407068 | chr3:607892-607893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2729248 | chr3:607898-607899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs201392226 | chr3:607901-607902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547847543 | chr3:607910-607911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183325845 | chr3:607911-607912 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12636550 | chr3:608041-608042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187888687 | chr3:608044-608045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529804132 | chr3:608081-608082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548099690 | chr3:608085-608086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191189150 | chr3:608120-608121 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537057926 | chr3:608122-608123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111559494 | chr3:608123-608124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538125856 | chr3:608136-608137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148410451 | chr3:608160-608161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564268535 | chr3:608172-608173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142495769 | chr3:608213-608214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116025227 | chr3:608244-608245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184536881 | chr3:608253-608254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533272408 | chr3:608254-608255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147749742 | chr3:608286-608287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576621826 | chr3:608305-608306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2729249 | chr3:608332-608333 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs146769144 | chr3:608367-608368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71719082 | chr3:608382-608383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2729250 | chr3:608405-608406 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs541142805 | chr3:608502-608503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559391991 | chr3:608512-608513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547037637 | chr3:608528-608529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9870187 | chr3:608552-608553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541582177 | chr3:608592-608593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2729251 | chr3:608623-608624 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs530756431 | chr3:608641-608642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540814089 | chr3:608666-608667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74344583 | chr3:608728-608729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536787549 | chr3:608752-608753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2729252 | chr3:608767-608768 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs189806138 | chr3:608853-608854 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs2729253 | chr3:608929-608930 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs568117284 | chr3:608986-608987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573524369 | chr3:609038-609039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540567861 | chr3:609089-609090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536848039 | chr3:609109-609110 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569275931 | chr3:609110-609111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34743679 | chr3:609136-609137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62236834 | chr3:609152-609153 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs570228171 | chr3:609175-609176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112097422 | chr3:609245-609246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192729666 | chr3:609255-609256 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149258937 | chr3:609260-609261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35134288 | chr3:609263-609264 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 20685689 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:607000-610000 | Weak transcription | Fetal Brain Male | brain |
2 | chr3:607600-608400 | Enhancers | Aorta | Aorta |
3 | chr3:608800-610600 | Enhancers | Brain Germinal Matrix | brain |
4 | chr3:610000-611200 | Enhancers | Fetal Brain Male | brain |
5 | chr3:610200-610600 | Enhancers | Ovary | ovary |
6 | chr3:611200-612400 | Weak transcription | Fetal Brain Male | brain |
7 | chr3:612600-612800 | Enhancers | Fetal Brain Male | brain |
8 | chr3:636400-642600 | Enhancers | Hela-S3 | cervix |
9 | chr3:639200-639800 | Enhancers | Dnd41 | blood |
10 | chr3:649000-650000 | Enhancers | Hela-S3 | cervix |
11 | chr3:649200-650200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:659600-660000 | Active TSS | Spleen | Spleen |